OpenAlex
PricingAboutJobs
Log inGet started
Work

Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC

HTML

Year: 2013
Type: article
Source: Molecular Cancer Research
DOI: 10.1158/1541-7786.mcr-12-0652
Authors: Hideki Terai, Kenzo Soejima, Hiroyuki Yasuda, Sohei Nakayama, Junko Hamamoto, Daisuke Arai, Kota Ishioka, Keiko Ohgino, Shinnosuke Ikemura, Takashi Sato, Satoshi Yoda, Ryosuke Satomi, Katsuhiko Naoki, Tomoko Betsuyaku
Institution: Keio University
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: gefitinib resistance, non-small cell lung cancer, EGFR tyrosine kinase inhibitors, acquired drug resistance, FGFR1, FGF2, PD173074, EGFR mutation, PC9 cell line, cell proliferation
SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science
Awards: Overcoming epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)-resistance in lung cancer through PI3-kinase pathway, Screening of fusion genes in non-small cell lung cancer
OpenAlex ID: W2122442582
FWCI: 14.95
Cites: 30
Cited by: 227
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms